SI1079803T1 - Protein formulations - Google Patents
Protein formulationsInfo
- Publication number
- SI1079803T1 SI1079803T1 SI9930678T SI9930678T SI1079803T1 SI 1079803 T1 SI1079803 T1 SI 1079803T1 SI 9930678 T SI9930678 T SI 9930678T SI 9930678 T SI9930678 T SI 9930678T SI 1079803 T1 SI1079803 T1 SI 1079803T1
- Authority
- SI
- Slovenia
- Prior art keywords
- protein formulations
- pharmaceutical formulations
- osteoporosis
- useful
- concentration
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 101001135770 Homo sapiens Parathyroid hormone Proteins 0.000 abstract 1
- 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 102000058004 human PTH Human genes 0.000 abstract 1
- 239000008181 tonicity modifier Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9801495A SE9801495D0 (sv) | 1998-04-28 | 1998-04-28 | Protein formulationa |
| EP99917715A EP1079803B1 (en) | 1998-04-28 | 1999-04-26 | Protein formulations |
| PCT/CA1999/000376 WO1999055353A2 (en) | 1998-04-28 | 1999-04-26 | Protein formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1079803T1 true SI1079803T1 (en) | 2005-02-28 |
Family
ID=20411122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9930678T SI1079803T1 (en) | 1998-04-28 | 1999-04-26 | Protein formulations |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20050209144A1 (cs) |
| EP (1) | EP1079803B1 (cs) |
| JP (2) | JP4733267B2 (cs) |
| KR (1) | KR100579872B1 (cs) |
| CN (1) | CN1172658C (cs) |
| AT (1) | ATE273693T1 (cs) |
| AU (2) | AU766514B2 (cs) |
| BR (1) | BR9909958A (cs) |
| CA (1) | CA2329800C (cs) |
| CY (1) | CY2006006I1 (cs) |
| DE (3) | DE122006000057I1 (cs) |
| DK (1) | DK1079803T3 (cs) |
| ES (1) | ES2224637T3 (cs) |
| FR (1) | FR06C0032I2 (cs) |
| HK (1) | HK1041218B (cs) |
| IL (1) | IL139320A (cs) |
| LU (1) | LU91281I2 (cs) |
| NL (1) | NL300243I2 (cs) |
| NZ (1) | NZ508269A (cs) |
| PT (1) | PT1079803E (cs) |
| SE (1) | SE9801495D0 (cs) |
| SI (1) | SI1079803T1 (cs) |
| WO (1) | WO1999055353A2 (cs) |
| ZA (1) | ZA200006040B (cs) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6770623B1 (en) | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
| SE9801495D0 (sv) * | 1998-04-28 | 1998-04-28 | Astra Ab | Protein formulationa |
| US20050032698A1 (en) * | 2003-07-14 | 2005-02-10 | Nps Allelix Corp. | Stabilized formulation of parathyroid hormone |
| US7994129B2 (en) * | 2005-11-10 | 2011-08-09 | Michigan Technological University | Methods of using black bear parathyroid hormone |
| US7803770B2 (en) | 2006-10-03 | 2010-09-28 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| USRE49444E1 (en) | 2006-10-03 | 2023-03-07 | Radius Health, Inc. | Method of treating osteoporosis comprising administration of PTHrP analog |
| WO2008063279A2 (en) | 2006-10-03 | 2008-05-29 | Radius Health, Inc. | A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof |
| FR2925333B1 (fr) * | 2007-12-19 | 2012-04-13 | Farid Bennis | Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives |
| JP2009091363A (ja) * | 2008-11-21 | 2009-04-30 | Asahi Kasei Pharma Kk | Ｐｔｈの安定化水溶液注射剤 |
| AU2009356227A1 (en) | 2009-12-07 | 2012-06-21 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| ES2833535T3 (es) * | 2011-06-07 | 2021-06-15 | Asahi Kasei Pharma Corp | Preparación liofilizada que contiene PTH de alta pureza y método para producirla |
| CN103301058A (zh) * | 2013-06-17 | 2013-09-18 | 深圳翰宇药业股份有限公司 | 一种特立帕肽注射用组合物及其制备方法和制剂 |
| EP3122426B1 (en) | 2014-03-28 | 2023-01-18 | Duke University | Treating breast cancer using selective estrogen receptor modulators |
| IL255189B2 (en) | 2015-04-29 | 2024-04-01 | Radius Pharmaceuticals Inc | A combination of rad1901 and a cdk4/6 inhibitor for use in treating cancer |
| CN106309358A (zh) * | 2015-06-29 | 2017-01-11 | 成都金凯生物技术有限公司 | 含有人甲状旁腺激素的药物组合物及其制备方法与用途 |
| RS65694B1 (sr) | 2017-01-05 | 2024-07-31 | Radius Pharmaceuticals Inc | Polimorfni oblici rad1901-2hcl |
| CN108333360A (zh) * | 2017-01-19 | 2018-07-27 | 深圳市新产业生物医学工程股份有限公司 | 胃泌素释放肽前体稀释液及其应用和试剂盒 |
| US10996208B2 (en) | 2017-04-28 | 2021-05-04 | Radius Health, Inc. | Abaloparatide formulations and methods of testing, storing, modifying, and using same |
| CN116898955A (zh) * | 2017-09-22 | 2023-10-20 | 旭化成制药株式会社 | 稳定性优异的含有特立帕肽的液态药物组合物 |
| CN108159404B (zh) * | 2018-01-05 | 2019-08-27 | 北京博康健基因科技有限公司 | 重组人甲状旁腺激素制剂及其制备方法 |
| JP7473486B2 (ja) | 2018-07-04 | 2024-04-23 | ラジウス ファーマシューティカルズ，インコーポレイテッド | Ｒａｄ１９０１－２ｈｃｌの多形形態 |
| JOP20210218A1 (ar) | 2019-02-12 | 2023-01-30 | Radius Pharmaceuticals Inc | عمليات ومركبات |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981485A (en) * | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| US5744444A (en) * | 1989-10-27 | 1998-04-28 | Haemopep Pharma Gmbh | HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof |
| DE3935738A1 (de) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
| US5547939A (en) * | 1991-06-14 | 1996-08-20 | The Regents Of The University Of California | Broad spectrum antimicrobial compounds and methods of use |
| JP2662842B2 (ja) * | 1991-12-09 | 1997-10-15 | 旭化成工業株式会社 | パラサイロイドホルモンの安定化組成物 |
| US5563122A (en) * | 1991-12-09 | 1996-10-08 | Asahi Kasei Kogyo Kabushiki Kaisha | Stabilized parathyroid hormone composition |
| ES2179831T3 (es) * | 1992-09-29 | 2003-02-01 | Inhale Therapeutic Syst | Liberacion en los pulmones de fragmentos activos de hormona paratiroidiana. |
| US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
| JPH09157294A (ja) * | 1995-06-15 | 1997-06-17 | Takeda Chem Ind Ltd | 副甲状腺ホルモン誘導体 |
| DE19538687A1 (de) * | 1995-10-17 | 1997-04-24 | Boehringer Mannheim Gmbh | Stabile pharmazeutische Darreichungsformen enthaltend Parathormon |
| JP4053107B2 (ja) * | 1996-02-01 | 2008-02-27 | 中外製薬株式会社 | 血小板減少症の予防剤および治療剤 |
| US5964807A (en) * | 1996-08-08 | 1999-10-12 | Trustees Of The University Of Pennsylvania | Compositions and methods for intervertebral disc reformation |
| DE19733651A1 (de) * | 1997-08-04 | 1999-02-18 | Boehringer Ingelheim Pharma | Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole |
| SE9801495D0 (sv) * | 1998-04-28 | 1998-04-28 | Astra Ab | Protein formulationa |
-
1998
- 1998-04-28 SE SE9801495A patent/SE9801495D0/xx unknown
-
1999
- 1999-04-26 WO PCT/CA1999/000376 patent/WO1999055353A2/en not_active Ceased
- 1999-04-26 EP EP99917715A patent/EP1079803B1/en not_active Expired - Lifetime
- 1999-04-26 DE DE1999619533 patent/DE122006000057I1/de active Pending
- 1999-04-26 AT AT99917715T patent/ATE273693T1/de active
- 1999-04-26 HK HK02102980.6A patent/HK1041218B/zh not_active IP Right Cessation
- 1999-04-26 AU AU35916/99A patent/AU766514B2/en not_active Expired
- 1999-04-26 ES ES99917715T patent/ES2224637T3/es not_active Expired - Lifetime
- 1999-04-26 PT PT99917715T patent/PT1079803E/pt unknown
- 1999-04-26 DE DE69919533T patent/DE69919533T2/de not_active Expired - Lifetime
- 1999-04-26 DE DE122006000057C patent/DE122006000057I2/de active Active
- 1999-04-26 JP JP2000545551A patent/JP4733267B2/ja not_active Expired - Lifetime
- 1999-04-26 CA CA002329800A patent/CA2329800C/en not_active Expired - Lifetime
- 1999-04-26 IL IL139320A patent/IL139320A/en not_active IP Right Cessation
- 1999-04-26 DK DK99917715T patent/DK1079803T3/da active
- 1999-04-26 CN CNB998073628A patent/CN1172658C/zh not_active Expired - Lifetime
- 1999-04-26 BR BR9909958-6A patent/BR9909958A/pt not_active Application Discontinuation
- 1999-04-26 NZ NZ508269A patent/NZ508269A/en not_active IP Right Cessation
- 1999-04-26 SI SI9930678T patent/SI1079803T1/xx unknown
- 1999-04-26 KR KR1020007012037A patent/KR100579872B1/ko not_active Expired - Lifetime
-
2000
- 2000-10-26 ZA ZA200006040A patent/ZA200006040B/en unknown
-
2004
- 2004-01-16 AU AU2004200156A patent/AU2004200156B2/en not_active Expired
- 2004-11-30 US US10/999,160 patent/US20050209144A1/en not_active Abandoned
-
2006
- 2006-10-17 NL NL300243C patent/NL300243I2/nl unknown
- 2006-10-19 LU LU91281C patent/LU91281I2/fr unknown
- 2006-10-20 FR FR06C0032C patent/FR06C0032I2/fr active Active
- 2006-10-23 CY CY200600006C patent/CY2006006I1/el unknown
-
2011
- 2011-01-24 JP JP2011011811A patent/JP5753692B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1079803T1 (en) | Protein formulations | |
| IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
| MY120984A (en) | Activated protein c formulations | |
| BR0008059A (pt) | Composições de valdecoxib | |
| ZA965235B (en) | Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders | |
| AP9801269A0 (en) | Prostaglandin agonists. | |
| MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
| BG102660A (en) | Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders | |
| BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
| MXPA02011533A (es) | Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona. | |
| UA66932C2 (en) | Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine | |
| WO2001083722A3 (en) | Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly | |
| IL164317A0 (en) | Statin therapy for enhancing cognitive maintenance | |
| GB9823515D0 (en) | Agent for the treatment of osteoporosis | |
| HUP0103149A3 (en) | Pharmaceutical composition for treatment of alzheimer's disease | |
| ATE170191T1 (de) | Physiologisch aktive peptide und den calcium- metabolismus regulierende arzneimittel, die genannte peptide als wirkungsvollen bestandteil enthalten | |
| IT1307866B1 (it) | Composizioni farmaceutiche contenenti inibitori dell'ormone dellacrescita o loro frammenti biologicamente attivi per il trattamento | |
| UA30798A (uk) | Спосіб пролонгованої терапії онкологічних хворих | |
| MY118194A (en) | Pharmaceutical compositions for use in inhibiting bone resorption |